Stall in weeks 1 through 8 (early treatment) Most likely cause: sub-therapeutic dose
doi: 10.1186/s12970-016-0118-y 42 ZhangSLinXHouQHuZWangYWangZ
10% Experience Dizziness According to NP2GO, approximately 10% of patients experience dizziness when taking semaglutide, and early reports also note that dizziness was reported in 5% of patients during the first month of treatment, highlighting that early monitoring and simple adjustments often prevent escalation
Common Side Effects When Combining These Medications Nausea and vomiting are the most frequently reported side effects of GLP-1 therapy, occurring in 2050% of users depending on dose and individual sensitivity
Kerlikowsky, F., Krmer, K., Eggersdorfer, M., & Hahn, A
NNMT is a cytosolic enzyme that methylates nicotinamide (vitamin B3) using S-adenosylmethionine (SAM) as a methyl donor